Bank of New York Mellon’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bank of New York Mellon’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,126	Closed	-$3.6M	–	4506
2022 Q4	$3.6M	Buy	100,126 +23,092	+30%	+$577K	﹤0.01%	2530
2022 Q3	$1.16M	Buy	77,034 +14,069	+22%	+$228K	﹤0.01%	3132
2022 Q2	$843K	Buy	62,965 +11,336	+22%	+$180K	﹤0.01%	3301
2022 Q1	$995K	Buy	51,629 +23,661	+85%	+$491K	﹤0.01%	3321
2021 Q4	$664K	Buy	27,968 +3,693	+15%	+$85.6K	﹤0.01%	3622
2021 Q3	$487K	Buy	+24,275	New	+$521K	﹤0.01%	3824

Bank of New York Mellon's IMGO Position: Q1 2023 in Review

Bank of New York Mellon sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 100,126 shares — an estimated $3.6M sold.

Bank of New York Mellon first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $3.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Bank of New York Mellon reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Bank of New York Mellon sold 100,126 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $3.6M.
Bank of New York Mellon first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Bank of New York Mellon's Imago BioSciences, Inc. Common stock position peaked at $3.6M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.